Overall, CCR10–CCL27/CCL28 signaling exerts diverse, context-dependent roles in cancer promoting immune cell recruitment, tumor growth, invasion, angiogenesis, drug resistance, and immune evasion, while in some cases correlating with favorable outcomes. The gene discussed is CCL28; the disease is neoplasm.